Jim Henry

Managing Director

Stephen Hipp

Managing Director

Robert McDonald MD

Operating Partner

Shannon Rothschild

Managing Director

Steven Whitlock

Managing Director

6 past transactions

Interventional Pain Management

Private Equity Round in 2020
Address: 110 Stone Oak Pkwy, San Antonio TX 78258 Main Phone: 210-268-0129 Business Email: paindoc@sapaindoc.com Business Website: http://www.sapaindoc.com Interventional Pain Management under the guidance of Dr. Urfan Dar offers a unique approach to avoid chronic pain to maintain quality of life. Helping people alleviate back and neck pain in San Antonio and New Braunfels we are the best pain management doctors and specialists in the area. Call us today for a consultation. Services: Pain Management, Minimally Invasive Laser Spine Surgery Hours: Mon to Fri 8:00 AM to 5:00 PM , Sat & Sun : Closed Payment Methods: amex, debit, mc, discover, visa

Castle Biosciences

Venture Round in 2019
Castle Biosciences is a molecular diagnostics company headquartered in Friendswood, Texas, that develops and commercializes gene‑expression‑profile tests for dermatologic cancers, uveal melanoma, and Barrett’s esophagus. Its flagship product, DecisionDx‑Melanoma, predicts the risk of metastasis in stage I and II cutaneous melanoma by analyzing 31 tumor‑derived genes. The company also offers DecisionDx‑UM for uveal melanoma, DecisionDx‑SCC for cutaneous squamous cell carcinoma, MyPath Melanoma for diagnostically challenging melanocytic lesions, and TissueCypher for predicting progression of high‑grade dysplasia in Barrett’s esophagus. Tests are delivered to physicians, physician assistants, and nurse practitioners to support personalized treatment decisions. Founded in 2007, Castle Biosciences focuses on providing clinically actionable genomic information to improve cancer diagnosis and management.

Sanova Dermatology

Acquisition in 2018
Sanova Dermatology, PLLC is a comprehensive dermatology center located in Austin, Texas, specializing in both cosmetic and medical dermatology services. The company provides a wide range of treatments, including wrinkle reduction, acne management, psoriasis care, and skin cancer treatment. Its offerings encompass general dermatology, surgical dermatology, and aesthetic procedures such as Mohs micrographic surgery, dermal fillers, and Botox. Sanova Dermatology aims to deliver individualized skin-care solutions tailored to the unique needs of its patients, ensuring professional care and a commitment to high-quality dermatological services.

HNI Healthcare

Series E in 2018
HNI Healthcare is a technology-driven physician practice management company specializing in delivering comprehensive facility-based physician programs. By combining its physicians' expertise with advanced processes and technologies, HNI Healthcare helps healthcare facilities enhance key quality metrics through a more integrated care model.

Qspex Technologies

Debt Financing in 2015
QSpex Technologies, Inc. is an optical service center based in Alpharetta, Georgia, that specializes in producing high-quality finished eyewear in the United States. Founded in 2007, the company developed a patented method for manufacturing premium lenses directly in optical offices, allowing for a cost-effective and efficient process. Utilizing advanced touchless transfer technology, QSpex enables the quick fabrication of lenses, including single vision, progressive, anti-reflective, photochromic, and polar options, with lens treatments integrated during the production process. This innovative approach allows eyewear providers to deliver finished products to patients on the same day as their eye exams. However, the company filed for voluntary liquidation under Chapter 7 in June 2020.

Qspex Technologies

Series D in 2012
QSpex Technologies, Inc. is an optical service center based in Alpharetta, Georgia, that specializes in producing high-quality finished eyewear in the United States. Founded in 2007, the company developed a patented method for manufacturing premium lenses directly in optical offices, allowing for a cost-effective and efficient process. Utilizing advanced touchless transfer technology, QSpex enables the quick fabrication of lenses, including single vision, progressive, anti-reflective, photochromic, and polar options, with lens treatments integrated during the production process. This innovative approach allows eyewear providers to deliver finished products to patients on the same day as their eye exams. However, the company filed for voluntary liquidation under Chapter 7 in June 2020.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.